MultiCell Technologies OTC BB: MCET Investor Contact: MCETinvestor@multicelltech.com Transfer Agent U.S. Stock Transfer Corporation 1745 Gardena Avenue, Suite 200 Glendale, CA 91204-2991 Phone: (818) 502-1404 Fax: (818) 502-0674 http://www.usstock.com Shareholders, have you changed your address? Please e-mail: addchange@usstock.com For other transfer agent questions: info@usstock.com MultiCell believes that it has a solid platform of therapeutic pipeline candidates competing in key areas in which MultiCell is focused: MS, Type-1 diabetes, and infectious disease. The Company plans to pursue strategic alliances in order to better penetrate the various markets for their therapeutics. This site is designed to facilitate your access to timely information about the company and its subsidiaries.  Please contact us if you have additional questions or feedback about this site or the company.